$MPG (Metaldyne Performance Group Inc.)

$MPG {{ '2016-09-13T11:45:36+0000' | timeago}} • Announcement

$MPG announced planned closure of Wisconsin-based Brillion Iron Works, which was recently acquired from $ACW. The Brillion foundry will cease molding and melt operations in 4Q16. The existing Brillion business will be transferred to 5 MPG casting plants located in Browntown, WI; Reedsburg, WI; St. Cloud, MN; Iron Mountain, MI; and New Castle, IN.

$INFO {{ '2018-01-16T20:28:30+0000' | timeago}} • Infographic

$INFO IHS Markit Ltd. Earnings AlphaGraphic: Q4 2017 Highlights

$VVV {{ '2018-01-09T13:57:44+0000' | timeago}} • Announcement

$VVV, a producer of automotive lubricants, has appointed Brad Patrick as Chief People and Communications Officer. Patrick, who joins the company from Tempur Sealy International, will report to Valvoline's CEO Sam Mitchell. Previously, Patrick held key HR positions at Sara Lee, The Gillette, Delta Air Lines and Frito-Lay.

$INFO {{ '2018-01-03T13:30:22+0000' | timeago}} • Announcement

$INFO appointed Lord Browne of Madingley and Nicoletta Giadrossi as new directors of the company. Also, Lance Uggla, the company’s president and COO, became chairman and CEO of $INFO on Jan. 1, 2018, following the retirement of chairman and CEO Jerre Stead on Dec. 31, 2017.

$BWA {{ '2017-12-15T15:25:26+0000' | timeago}} • Announcement

$BWA announced the appointment of Frédéric Lissalde to EVP and chief operating officer, effective January 1, 2018.

$BIVV {{ '2017-12-11T20:56:54+0000' | timeago}} • Announcement

Biotechnology company $BIVV said results of the latest study conducted on its class monoclonal antibody BIVV009, indicated for the treatment of cold agglutinin disease,  achieved the primary and secondary endpoints. The endpoints included tolerability, pharmacokinetic profile supporting biweekly dosing, and classical complement pathway inhibition.

$BIVV {{ '2017-12-11T16:32:18+0000' | timeago}} • Announcement

$BIVV and Swedish Orphan Biovitrum AB said new data showed that individualized dosing with extended half-life therapy, Alprolix, every 14 or more days may be a potential option for people with severe hemophilia B who seek the benefits of protection from a prophylactic therapy with reduced treatment burden.

$AOBC {{ '2017-12-07T23:34:23+0000' | timeago}} • Announcement

$AOBC now sees 3Q18 net sales of $170-180MM generating a GAAP EPS of $0.01-0.04 and adjusted EPS of $0.07-0.10. For FY18, the firearm maker expects net sales of $650-675MM generating a GAAP EPS of $0.33-0.43 and adjusted EPS of $0.57-0.67.

$AOBC {{ '2017-12-07T23:31:45+0000' | timeago}} • Announcement

With wholesaler and retailer orders slumping, iconic Smith & Wesson firearm maker $AOBC saw quarterly net sales slump 36% to $148.4MM in 2Q18. Net income reduced to a measly $3.2MM or $0.06 per diluted share, about one-tenth f om last year's $32.5MM or $0.57 per diluted share.

$INFO {{ '2017-12-04T12:52:38+0000' | timeago}} • Announcement

$INFO closed its offering of $500MM of senior notes due 2026 in a private placement transaction. $INFO plans to use the net proceeds from this offering to repay amounts outstanding under its revolving credit facility.

$DWDP {{ '2017-12-01T20:09:10+0000' | timeago}} • Announcement

Dow Chemical proclaimed that it had completed the sale of a part of its Dow AgroSciences' corn seed business in Brazil to China’s CITIC for $1.1Bil. Dow, a subsidiary of $DWDP, sold the seed business as part of the conditional regulatory approval from Brazil's Administrative Council for Economic Defense for its recently completed merger with DuPont.

$INFO {{ '2017-11-30T13:08:02+0000' | timeago}} • Announcement

$INFO has priced an offering of $500MM  aggregate principal amount of senior notes due 2026. The offering is expected to close on December 1, 2017. The company intends to use the net proceeds from the offering to repay amounts outstanding under its revolving credit facility.

$BIVV {{ '2017-11-27T16:50:11+0000' | timeago}} • Announcement

$BIVV said the FDA has approved updated labeling for ALPROLIX, the extended half-life therapy for the treatment of patients with hemophilia B. These updates are based on interim data from the Phase 3 B-YOND open-label extension trial and final data from the Phase 3 Kids B-LONG pediatric study.

$BHF {{ '2017-11-16T17:28:01+0000' | timeago}} • Infographic

$BHF Brighthouse Financial, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$VVV {{ '2017-11-15T12:18:30+0000' | timeago}} • Announcement

$VVV has increased the quarterly cash dividend on the company’s common stock by more than 50%, from $0.049 to $0.0745 per share. The dividend will be payable on Dec. 15, 2017, to shareholders of record as of the close of business on Dec. 1, 2017.

$BWA {{ '2017-11-09T17:32:53+0000' | timeago}} • Infographic

$BWA BorgWarner Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$DWDP {{ '2017-11-03T17:45:17+0000' | timeago}} • Announcement

Amid investors pressure on realigning few operations in Agriculture, Specialty Products and Materials Science business units, $DWDP reported its first quarterly earnings after the Dow-DuPont merger. Net sales jumped 23% to $15.3Bil for the third quarter of 2017. GAAP EPS plunged 49% to $0.32, while pro forma adj. EPS rose 10% to $0.55.

$DWDP {{ '2017-11-02T15:21:30+0000' | timeago}} • Infographic

$DWDP DowDuPont Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$DAN {{ '2017-10-30T18:15:51+0000' | timeago}} • Announcement

$DAN, an automobile engineering firm, has appointed Nick Stavrakis as Managing Director for its Australia and New Zealand operations, effective November 20. Most recently, Stavrakis served SAF-Holland Australia as Managing Director. He has held various leadership positions in the industry, including CEO and Business Development.

$VVV {{ '2017-10-02T21:27:08+0000' | timeago}} • Announcement

$VVV has completed the acquisition of 56 Valvoline Instant Oil ChangeSM (VIOC) franchise service centers from Henley Bluewater LLC. Following the acquisition, the company has a network of 439 company-owned locations.

$SGMO {{ '2017-10-02T16:06:18+0000' | timeago}} • Announcement

$SGMO and $BIVV said the FDA has accepted the Investigational New Drug (IND) application for ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. $SGMO expects to open several clinical sites across the United States and begin enrolling patients in 1H18.

Recent Transcripts

INFO (IHS Markit Ltd.)
Tuesday, January 16 2018 - 1:00pm
SHLO (Shiloh Industries Inc.)
Friday, January 5 2018 - 1:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, December 7 2017 - 10:00pm
HOME (At Home Group Inc.)
Wednesday, November 29 2017 - 9:30pm
VVV (Valvoline Inc.)
Thursday, November 9 2017 - 2:00pm
MGA (Magna International Inc.)
Thursday, November 9 2017 - 1:00pm
AXL (American Axle & Manufacturing Holdings Inc.)
Friday, November 3 2017 - 2:00pm
BHF (Brighthouse Financial, Inc.)
Thursday, November 2 2017 - 4:00pm
DWDP (DowDuPont Inc.)
Thursday, November 2 2017 - 12:00pm
BIVV (Bioverativ Inc.)
Friday, October 27 2017 - 12:00pm
ITGR (Integer Holdings Corporation)
Thursday, October 26 2017 - 9:00pm
DAN (Dana Holding Corporation)
Thursday, October 26 2017 - 3:00pm
BWA (BorgWarner Inc.)
Thursday, October 26 2017 - 2:00pm
INFO (IHS Markit Ltd.)
Tuesday, September 26 2017 - 12:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, September 7 2017 - 9:00pm
HOME (At Home Group Inc.)
Tuesday, September 5 2017 - 8:30pm
SHLO (Shiloh Industries Inc.)
Tuesday, August 29 2017 - 12:00pm
MGA (Magna International Inc.)
Friday, August 11 2017 - 12:00pm
BIVV (Bioverativ Inc.)
Thursday, August 3 2017 - 12:00pm
VVV (Valvoline Inc.)
Wednesday, August 2 2017 - 3:00pm

AlphaGraphics you may like